Biologics manufacturers cite complex research and development process,along with FDA scrutiny, as reason for costly - but worthy - drugs
Derm In The News: September 17-23
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
CeraVe Partners With George Washington University to Expand Residency Training Program
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Combination Treatments in HS Require Further Review
Frontline Forum Part 4: Improving Basal Cell Carcinoma Management